Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
<br><strong>Background </strong>Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. <br><strong> Methods </...
المؤلفون الرئيسيون: | de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
BMJ Publishing Group
2021
|
مواد مشابهة
-
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
حسب: de Vlam, K, وآخرون
منشور في: (2018) -
Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
حسب: Ogdie, A, وآخرون
منشور في: (2018) -
Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
حسب: de Vlam, K, وآخرون
منشور في: (2022) -
Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
حسب: Taylor, P, وآخرون
منشور في: (2019) -
Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
حسب: Taylor, PC, وآخرون
منشور في: (2020)